Search clinical trials for: RO5323441

Total 4 results

Hoffmann-La Roche

Completed

A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian Cancer

Colorectal Cancer, Ovarian Cancer

Belgium, Spain, United Kingdom
University Medical Center Groningen

Withdrawn

89Zr-RO5323441 PET Imaging in Glioblastoma

Glioblastoma

Netherlands
Hoffmann-La Roche

Completed

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Glioblastoma Multiforme

Switzerland, France, United Kingdom, Denmark
Hoffmann-La Roche

Completed

A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Singapore

3

Subscribe